hyderabad on a day union health minister mansukh mandaviya reiterated the indian governments zero tolerance policy on spurious medicines by asking 18 companies to shut shop pharmexcil director general r uday bhaskar said though exports have not been impacted the issue has dented indias image as the pharmacy of the worldwho and regulators of different countries are talking about it and issuing public alerts whenever we have interactions with regulators the first point they want to discuss is on these issues only bhaskar saidthis was though cough syrups accounted for just 15 million of indias total pharma exports of 254 billion in 202223 and 52 of indias pharma exports go to stringently regulated markets like europe where exports recorded 155 growth for the first time and us on india falling short of the 27 billion target bhaskar said though exports grew only 325 in fy23 to 254 billion pharmexcil was gunning for 28 billion exports in 202324 as the us market which has 31 share of exports has stablised which is a positive signdespite global headwinds that led to negative growth in key markets such as africa 5 and cis 8 indian pharma crossed the 25 billion mark for the first time and grew 105 in april 2023 alone an optimistic bhaskar said while addressing mediapersons on the ninth edition of pharmexcils flagship international pharma exhibition to be held in hyderabad from july 5 to 7 he said iphex 2023 is a special edition being organised on the occasion of indias g20 presidency and will include a g20 focussed ceos roundtable of delegates from over 120 countries